{"ticker": {"uuid": "9eeb0330-7de4-463c-8e1f-b329fe1eba84", "symbol": "8329", "name": "Shenzhen Neptunus Interlong Bio-technique Company Limited", "exchange": "HKG", "country": "HK", "sector": "Healthcare", "industry": "Drug Manufacturers - Specialty & Generic"}, "articles": [{"title": "Enterprise value to EBITDA forward of Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H \u2013 HKEX:8329", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNeWxwQlNacEJvLVhrbkM1bC10d1lPZ05OcUlVYW5tdVdVdGk3R3lzMzBKczlyVk9SU1VmMUVkRUlGRXEwM2JyTmtrZlJhdi1zcGswaE5BelVFYW5SMEw0WGZnT3hlRlk4eHNSN3dEZnF6UjVFMnZiRnBFdGVLTlpvcE1GVE1XbDd5eklUVXpYeGJ1eDN0MUFfMGNvUllhbl9jMzROWXNQOGRsRDg?oc=5", "source_name": "TradingView", "published_at": "2026-07-07T08:34:43+00:00", "published_display": "07 Jul 2026 08:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H \u2013 HKEX:8329", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQeS13YTJOdGlmekZYRnhuYjNMUnJPVHU4NXMyY3BJbFNkSEc2Y19MQkhrVHRzZ283WGxZQXNES1BoY2tadWRXeGc2WGJ2VkNxbTZlZ3Z5eEktaGNZcTBEaEdXNjFFSGFQZTllckM4UnVYbE5hb19TcEliM2VWTEdFNUFtOS1veTFDZUc3c2hpZ2U4UUtfekRYaDhMaHRXSUV4WFRWTXFrN1g?oc=5", "source_name": "TradingView", "published_at": "2026-07-06T23:57:46+00:00", "published_display": "06 Jul 2026 23:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shenzhen Neptunus Interlong Bio-technique Company Limited Announces Board and Committee Changes", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPTHowWURqRHZ2R2hlZWZJXzBjN0tOWFJrV1FpYjUtVXphb0E2UkItOWhvYVFtc3RFVDl0VHZTRVZmOER3bWdUNzNHWHQyVlR6MzM5RWZFUWFDUTAyMERRZE1Wa2FsS293dTV1OVBCaTExNXlNMUFLX2ZBQlZoeldJNjZsYTlabGFfeDRlRHN5Yy1ZMFBzZHlsVHF2WHhLaDU4OHRsSTBBQXNYOS1tT205NElEWUZ0T0ppOEFLeTlfN0w5aDMzRnFhTFdkdnFrLS1PTnlHeGUwT2hiM0VUYnNRcUR3?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shenzhen Neptunus Interlong Bio-Technique Company Limited Announces Board Retirements", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPVlkwU3pUYm1XOWF3Y0VjQjE4enU0Rk02LVZuSUJJWEZPUXN2Sms4WE04U2VVV21tbkM5d2pNQW83RUVNWlhVc3VrcEx1VkJWUEtYd2V0ZXd1YUJrYi11WTE5NzR0cFY5clE4OUROSzFEWGVNd0YwamNWOEhvSUVhQ3hzODJzVXlTY1VfZ1BUc3NiRUJtUjBSR0t4RkFJNFI3TkZaSXY2Zzl3aVdZblQ1VWx3T0xPSVdJZUoxTFJ1Nkx5c0ZManJ5VEg4blRfSVl2czBGcw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GSK to purchase Shenzhen Neptunus stake in previously formed joint venture for influenza vaccines in China", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxNQjhUZzVVS2dQOEk3ZTVQeHM1LU5OYTVfb1BrOFA0aWF5SnhadERNTDduc1VxX2kwVnZMdmphN2Z6TTFmQXo1enh3SmlDMGxJSDVIVHI2RzdGM0hIRVdKcTdoQ3BvbGg3WDhEQXJDQ3ZxUXk1VTA4eHZlci1aVFZJdndKRVNoSzZLVWZZWTU5Q1FqaDBkQWZ4YWJvSllzX3lGbUFGY3dpRkIzcmktMFc3Tk5jTDRJR2p1X1JsWVQ0M28wX3lCVVY2bWk2WHFGTERjbVNfR1VvZ19IRzV6WTZTdzRRbmwwMjJXdkE?oc=5", "source_name": "GSK", "published_at": "2011-06-14T07:00:00+00:00", "published_display": "14 Jun 2011 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Enterprise value to EBITDA forward of Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H \u2013 HKEX:8329", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxNeWxwQlNacEJvLVhrbkM1bC10d1lPZ05OcUlVYW5tdVdVdGk3R3lzMzBKczlyVk9SU1VmMUVkRUlGRXEwM2JyTmtrZlJhdi1zcGswaE5BelVFYW5SMEw0WGZnT3hlRlk4eHNSN3dEZnF6UjVFMnZiRnBFdGVLTlpvcE1GVE1XbDd5eklUVXpYeGJ1eDN0MUFfMGNvUllhbl9jMzROWXNQOGRsRDg?oc=5", "source_name": "TradingView", "published_at": "2026-07-07T08:34:43+00:00", "published_display": "07 Jul 2026 08:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Enterprise value to EBIT forward of Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H \u2013 HKEX:8329", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQeS13YTJOdGlmekZYRnhuYjNMUnJPVHU4NXMyY3BJbFNkSEc2Y19MQkhrVHRzZ283WGxZQXNES1BoY2tadWRXeGc2WGJ2VkNxbTZlZ3Z5eEktaGNZcTBEaEdXNjFFSGFQZTllckM4UnVYbE5hb19TcEliM2VWTEdFNUFtOS1veTFDZUc3c2hpZ2U4UUtfekRYaDhMaHRXSUV4WFRWTXFrN1g?oc=5", "source_name": "TradingView", "published_at": "2026-07-06T23:57:46+00:00", "published_display": "06 Jul 2026 23:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shenzhen Neptunus Interlong Bio-technique Company Limited Announces Board and Committee Changes", "summary": "", "url": "https://news.google.com/rss/articles/CBMi4gFBVV95cUxPTHowWURqRHZ2R2hlZWZJXzBjN0tOWFJrV1FpYjUtVXphb0E2UkItOWhvYVFtc3RFVDl0VHZTRVZmOER3bWdUNzNHWHQyVlR6MzM5RWZFUWFDUTAyMERRZE1Wa2FsS293dTV1OVBCaTExNXlNMUFLX2ZBQlZoeldJNjZsYTlabGFfeDRlRHN5Yy1ZMFBzZHlsVHF2WHhLaDU4OHRsSTBBQXNYOS1tT205NElEWUZ0T0ppOEFLeTlfN0w5aDMzRnFhTFdkdnFrLS1PTnlHeGUwT2hiM0VUYnNRcUR3?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-25T07:00:00+00:00", "published_display": "25 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Shenzhen Neptunus Interlong Bio-Technique Company Limited Announces Board Retirements", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPVlkwU3pUYm1XOWF3Y0VjQjE4enU0Rk02LVZuSUJJWEZPUXN2Sms4WE04U2VVV21tbkM5d2pNQW83RUVNWlhVc3VrcEx1VkJWUEtYd2V0ZXd1YUJrYi11WTE5NzR0cFY5clE4OUROSzFEWGVNd0YwamNWOEhvSUVhQ3hzODJzVXlTY1VfZ1BUc3NiRUJtUjBSR0t4RkFJNFI3TkZaSXY2Zzl3aVdZblQ1VWx3T0xPSVdJZUoxTFJ1Nkx5c0ZManJ5VEg4blRfSVl2czBGcw?oc=5", "source_name": "marketscreener.com", "published_at": "2026-06-03T07:00:00+00:00", "published_display": "03 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "GSK to purchase Shenzhen Neptunus stake in previously formed joint venture for influenza vaccines in China", "summary": "", "url": "https://news.google.com/rss/articles/CBMi6gFBVV95cUxNQjhUZzVVS2dQOEk3ZTVQeHM1LU5OYTVfb1BrOFA0aWF5SnhadERNTDduc1VxX2kwVnZMdmphN2Z6TTFmQXo1enh3SmlDMGxJSDVIVHI2RzdGM0hIRVdKcTdoQ3BvbGg3WDhEQXJDQ3ZxUXk1VTA4eHZlci1aVFZJdndKRVNoSzZLVWZZWTU5Q1FqaDBkQWZ4YWJvSllzX3lGbUFGY3dpRkIzcmktMFc3Tk5jTDRJR2p1X1JsWVQ0M28wX3lCVVY2bWk2WHFGTERjbVNfR1VvZ19IRzV6WTZTdzRRbmwwMjJXdkE?oc=5", "source_name": "GSK", "published_at": "2011-06-14T07:00:00+00:00", "published_display": "14 Jun 2011 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 48, "total_relevant": 5, "sentiment_summary": {"positive": 0, "negative": 0, "neutral": 5, "score": 50, "total": 5, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 76, "events": [{"event": "general", "label": "Market update", "weight": 2.2, "count": 4}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.12, "latest_week": "2026-07-10", "one_week_move": 15.1, "four_week_move": 24.5, "twelve_week_move": -5.4, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.80573, "market_dynamics_buy_signal": false, "relative_strength": -8.711548, "fair_value_gap": 8.7, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "negative", "expectation_probability": 44.1803, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+15.1% over one week, +24.5% over four weeks, trend inactive, and near fair-value range."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 57, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "TradingView", "count": 2}, {"label": "marketscreener.com", "count": 2}, {"label": "GSK", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 5}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 4}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "50/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "76/100 classification confidence."}, {"label": "Company focus", "value": "5", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+15.1% over one week, +24.5% over four weeks, trend inactive, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Enterprise value to EBITDA forward of Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. Class H \u2013 HKEX:8329"}], "updated_at": "2026-07-18T11:40:35.454131+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}